Effect of Glycemic Control on Periodontal Parameters in People with Type 2 Diabetes: A Single-Arm Interventional Pilot Trial
Experimental and Clinical Endocrinology & Diabetes · 2026-10-20
DOI: 10.1055/a-2958-3572 ↗Abstract
Abstract Periodontitis and type 2 diabetes show a bidirectional relationship. This pilot study investigated the possible association between glycemic control and periodontal status in people with type 2 diabetes without periodontal treatment. People with inadequately controlled type 2 diabetes (HbA1c value ≥ 8.0%) received intensified antihyperglycemic therapy. Periodontal and metabolic parameters were assessed at baseline (T1) and after 3 months (T2). No dental prophylaxis or subgingival instrumentation was performed. Clinical assessments included pocket probing depths, bleeding on probing, clinical attachment level, periodontal inflamed surface area, plaque index, and gingival index. The primary outcome parameter was the periodontal inflamed surface area. Patients’ oral health-related quality of life was assessed with the OHIP-G14 questionnaire. A significant reduction of HbA1c from average 9.3% to 8.2% after 3.8±1.1 months resulted in significant reductions of periodontal inflamed surface area and bleeding on probing (p=0.001 and p=0.001). Higher HbA1c values were significantly associated with higher periodontal inflamed surface area (p=0.006) and bleeding on probing values (p=0.026). No significant change was observed in OHIP-G14 scores. This study suggests that improved glycemic control may be associated with reduced periodontal inflammation (bleeding on probing and periodontal inflamed surface area), even without periodontal therapy. These findings support the importance of good glycemic control for periodontal health in people with type 2 diabetes. Given the exploratory nature of this study, these findings require cautious interpretation and confirmation in larger prospective studies.
EUVIMED